Replies to post #197 on ProMIS Neurosciences Inc (PMN)

[Amatuer17]

The space is good - the technology in pre-clinical - 9 to 10 months from starting 1st clinical trial

200 million o/s shares mean - around $75-80 million market cap - higher than one would expect

Unless someone in desperation to enter CNS area goes for BO - this will remain here or lower

Look at TNXP - it has PTSD drug in P3 trial - interim readout in Q3 - still market cap 24 million

That is a good near term gamble compared to this

[noretreat]

that is the million dollar question. seems to be fairly stable at this level for now.